Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Keeps you up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
![Essential](https://www.g2intelligence.com/wp-content/uploads/2023/11/Essential.png)
![62934_G2_Subscription Website Images_JL V1](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V1.png)
![Special-Report](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Report.png)
![62934_G2_Subscription Website Images_JL V12](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V12.png)
![Special-Analysis](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Analysis.png)
![Elite](https://www.g2intelligence.com/wp-content/uploads/2023/11/Elite.png)
Additional Business Intelligence Offerings
Lab Industry Advisor Subscriptions Include
![paper_magnifing_glass_512](https://www.g2intelligence.com/wp-content/uploads/2023/11/paper_magnifing_glass_512.png)
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
Medicare Coverage: NGS Testing of Early-Stage Cancer Patients Is Back in Play
From - National Intelligence Report
The reimbursement outlook for those who provide next generation sequencing (NGS) testing to early-stage cancer of Medicare patients with…
Rule-In Using High-Sensitivity Cardiac Troponin May Misdiagnose Heart Attacks
From - Diagnostic Testing & Emerging Technologies
One in 20 patients without clinical suspicion of acute myocardial infarction has a high sensitivity cardiac troponin I (hs-cTnI) level greater than…
The Dx Pipeline: A Roundup of the Month’s Key New Product Launches
From - Laboratory Industry Report
Here's a summary of the key product launches from late April to late May, 2019…
Compliance Perspectives: How to Implement a Respiratory Protection Program at Your Lab
From - Lab Compliance Advisor
Worker exposure to infection and hazardous substances is a constant and pressing challenge for lab managers. And if yours is among the many labs where workers are required…
Business Best Practices: The 5 Essential Components of a Marketing Plan
From - Laboratory Industry Report
Although there's no single formula for marketing a lab, there are five basic elements a marketing plan should include&…
Partnerships, IT Solutions Improve Infectious Disease Diagnostic Stewardship
From - Diagnostic Testing & Emerging Technologies
Appropriate use of testing is becoming a greater challenge, given the growing number of available diagnostic tests and their increasing complexity&…
Labs In Court: A roundup of recent cases and enforcement actions involving the diagnostics industry
From - National Intelligence Report
Case: One of the biggest Medicaid diagnostics fraud schemes in recent memory has resulted in multiple convictions, including&…
Brief Your CEO: Explain How New DOJ Guidance Can Get Your Lab Out of FCA Hot Water
From - Lab Compliance Advisor
New guidance from the DOJ lays out sheds light on a crucial matter that many high-ranking lab executives are forced to&…